Literature DB >> 2307186

Experimental observations on the pathogenesis of necrobacillosis.

G R Smith1, L M Wallace, D E Noakes.   

Abstract

Earlier studies showed that the minimum infective dose (greater than 10(6) organisms) of a virulent strain of Fusobacterium necrophorum could be greatly reduced by suspending the fusobacteria in sub-lethal doses of cultures of other bacteria such as Escherichia coli before inoculating mice subcutaneously. In the present study the infective dose of the same strain of F. necrophorum was reduced by a factor of greater than 10(3) by suspending the fusobacteria in sub-lethal doses of 5% homogenate of gaur or wallaby faeces. Sterile faecal filtrate had no such effect. The sites of low grade infection produced by the prior subcutaneous injection of E. coli culture or gaur faecal suspension were susceptible to superinfection by doses of F. necrophorum far below those required to infect normal tissue. This work helps to explain the production of necrobacillosis by the faecal contamination of small wounds. It proved impossible, however, to produce necrobacillosis in mice by the subcutaneous injection of faecal suspensions from 33 farm cattle. This suggests that the proportion of cattle with virulent F. necrophorum in their faeces is low.

Entities:  

Mesh:

Year:  1990        PMID: 2307186      PMCID: PMC2271731          DOI: 10.1017/s0950268800054546

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  7 in total

1.  [Observations concerning 7 strains of Saphaerophorus necrophorus, Sphaerophorus funduliformis, and Sphaerophorus pseudonecrophorus species].

Authors:  H Beerens; L Fievez; P Wattre
Journal:  Ann Inst Pasteur (Paris)       Date:  1971-07

2.  Physiological and biochemical characteristics of Fusobacterium necrophorum biovar A and biovar B strains and their deoxyribonucleic acid homology.

Authors:  T Shinjo; S Miyazato; C Kaneuchi; T Mitsuoka
Journal:  Nihon Juigaku Zasshi       Date:  1981-04

3.  Gas-lipuid chromatographic analysis of metabolic products in the identification of bacteroidaceae of clinical interest.

Authors:  A G Deacon; B I Duerden; W P Holbrook
Journal:  J Med Microbiol       Date:  1978-05       Impact factor: 2.472

4.  Enhancement of the infectivity of Fusobacterium necrophorum by other bacteria.

Authors:  G R Smith; D Till; L M Wallace; D E Noakes
Journal:  Epidemiol Infect       Date:  1989-06       Impact factor: 2.451

5.  The pathogenic properties of Fusobacterium and Bacteroides species from wallabies and other sources.

Authors:  G R Smith; J C Oliphant; R Parsons
Journal:  J Hyg (Lond)       Date:  1984-04

6.  Susceptibility of wallabies to Fusobacterium necrophorum.

Authors:  G R Smith; A Turner; R Cinderey
Journal:  Vet Rec       Date:  1986-06-21       Impact factor: 2.695

7.  Studies of Fusobacterium necrophorum from bovine hepatic abscesses: biotypes, quantitation, virulence, and antibiotic susceptibility.

Authors:  J N Berg; C M Scanlan
Journal:  Am J Vet Res       Date:  1982-09       Impact factor: 1.156

  7 in total
  4 in total

Review 1.  Fusobacterium necrophorum infections: virulence factors, pathogenic mechanism and control measures.

Authors:  Z L Tan; T G Nagaraja; M M Chengappa
Journal:  Vet Res Commun       Date:  1996       Impact factor: 2.459

2.  A sensitive method for isolating Fusobacterium necrophorum from faeces.

Authors:  G R Smith; S A Barton; L M Wallace
Journal:  Epidemiol Infect       Date:  1991-04       Impact factor: 2.451

3.  Further observations on enhancement of the infectivity of Fusobacterium necrophorum by other bacteria.

Authors:  G R Smith; S A Barton; L M Wallace
Journal:  Epidemiol Infect       Date:  1991-04       Impact factor: 2.451

Review 4.  Human infection with Fusobacterium necrophorum (Necrobacillosis), with a focus on Lemierre's syndrome.

Authors:  Terry Riordan
Journal:  Clin Microbiol Rev       Date:  2007-10       Impact factor: 26.132

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.